Thrivent Financial For Lutherans Emergent Bio Solutions Inc. Transaction History

Thrivent Financial For Lutherans

$52.6 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$7.35 - $13.21 $7,717 - $13,870	-1,050 Reduced 2.39%	42,951 $316,000
Q1 2023 May 17, 2023	SELL	$7.79 - $16.29 $12,019 - $25,135	-1,543 Reduced 3.39%	44,001 $456,000
Q4 2022 Feb 08, 2023	SELL	$11.0 - $21.45 $3,619 - $7,057	-329 Reduced 0.72%	45,544 $538,000
Q3 2022 Nov 14, 2022	BUY	$20.09 - $35.8 $38,994 - $69,487	1,941 Added 4.42%	45,873 $963,000
Q2 2022 Aug 16, 2022	BUY	$27.42 - $43.63 $135,811 - $216,099	4,953 Added 12.71%	43,932 $1.36 Million
Q1 2022 May 13, 2022	SELL	$36.48 - $52.22 $1.59 Million - $2.27 Million	-43,458 Reduced 52.72%	38,979 $1.6 Million
Q4 2021 Feb 16, 2022	BUY	$33.11 - $55.01 $2.32 Million - $3.85 Million	69,944 Added 559.87%	82,437 $3.58 Million
Q3 2021 Nov 15, 2021	BUY	$50.07 - $66.05 $20,128 - $26,552	402 Added 3.32%	12,493 $626,000
Q2 2021 Aug 19, 2021	BUY	$56.61 - $80.46 $2,660 - $3,781	47 Added 0.39%	12,091 $762,000
Q1 2021 May 17, 2021	BUY	$86.23 - $125.19 $21,557 - $31,297	250 Added 2.12%	12,044 $1.12 Million
Q4 2020 Feb 16, 2021	SELL	$79.17 - $111.47 $25,492 - $35,893	-322 Reduced 2.66%	11,794 $1.06 Million
Q3 2020 Nov 10, 2020	SELL	$81.91 - $134.94 $2.06 Million - $3.4 Million	-25,185 Reduced 67.52%	12,116 $1.25 Million
Q2 2020 Aug 12, 2020	BUY	$54.33 - $89.52 $28,523 - $46,998	525 Added 1.43%	37,301 $2.95 Million
Q1 2020 May 15, 2020	BUY	$49.34 - $68.76 $90,588 - $126,243	1,836 Added 5.25%	36,776 $2.13 Million
Q4 2019 Feb 13, 2020	BUY	$51.21 - $59.06 $4,660 - $5,374	91 Added 0.26%	34,940 $1.89 Million
Q3 2019 Nov 14, 2019	SELL	$40.6 - $57.2 $20,218 - $28,485	-498 Reduced 1.41%	34,849 $1.82 Million
Q2 2019 Aug 13, 2019	BUY	$39.92 - $53.86 $44,870 - $60,538	1,124 Added 3.28%	35,347 $1.71 Million
Q1 2019 May 14, 2019	BUY	$48.23 - $66.16 $126,700 - $173,802	2,627 Added 8.31%	34,223 $1.73 Million
Q4 2018 Feb 15, 2019	BUY	$55.63 - $73.24 $88,785 - $116,891	1,596 Added 5.32%	31,596 $1.87 Million
Q3 2018 Nov 15, 2018	BUY	$52.05 - $66.51 $298,402 - $381,301	5,733 Added 23.62%	30,000 $1.98 Million
Q2 2018 Aug 14, 2018	BUY	$48.33 - $55.64 $32,332 - $37,223	669 Added 2.83%	24,267 $1.23 Million
Q1 2018 May 08, 2018	BUY	$44.44 - $54.39 $80,347 - $98,337	1,808 Added 8.3%	23,598 $1.24 Million
Q4 2017 Feb 14, 2018	BUY	$37.77 - $47.75 $16,241 - $20,532	430 Added 2.01%	21,790 $1.01 Million
Q3 2017 Nov 14, 2017	BUY	$34.14 - $40.45 $729,230 - $864,012	21,360	21,360 $864,000

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$32.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$28.6 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$21 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$18.7 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$16.1 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account